Likvor receives an order for a Likvor CELDA® system from Örebro University Hospital, Sweden
With Likvor CELDA® system
the Örebro University Hospital will be able to measure the dynamics
of the most important parameters concerning the patients'
cerebrospinal fluid including pressure and flow in a controlled and
safe process. Likvor CELDA® was developed to facilitate
greater understanding and enhance diagnosis of normal pressure
hydrocephalus (NPH) a condition that is often mistaken for
dementia.
Hidden and misdiagnosed disease
Normal Pressure Hydrocephalus (NPH) is a relatively unknown
disease that is often mistakenly diagnosed as dementia, Alzheimer's
or Parkinson's. This is because the symptoms, including
disturbances in gait, confusion and urinary incontinence, are
similar to those of dementia, plus that NPH is a condition that
mainly occurs in people over the age of 55. Studies have shown that
up to 10 percent of dementia patients may actually be suffering
from NPH. The condition is many times referred to as reversible or
treatable dementia.
Likvor CELDA® is the most advanced instrument for
assessing the flow of cerebrospinal fluid (CSF) that surrounds the
brain and spinal cord. It increases the possibility for patients
who suffer from NPH to receive a correct diagnosis and the
appropriate treatment in the form of a shunt implant that diverts
and regulates CSF pressure and flow. An accurate diagnosis means
large gains for the patient and family, but also for society as a
whole.
Likvor CELDA® is used with a special developed
catheter, CELDA® TOOLS that is a disposable unit for one
time use only.
For further information about Likvor and the Likvor
CELDA® system, please visit /
or:
Please contact:
Kjell Öberg, CEO LIKVOR: +46 70 640 14 92
Magnus Liljeqvist, Sales and Marketing Director LIKVOR +46
70 314 41 31
Press release: December 6, 2010